Agenus Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | Agenus Inc.

Agenus Inc. | Ownership

Companies that own Agenus Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

RTW Investments LP

9,375,451

8.27%

61,895

1.19%

06/30/2018

BlackRock Fund Advisors

5,066,495

4.47%

487,287

06/30/2018

The Vanguard Group, Inc.

4,180,008

3.69%

675,347

06/30/2018

Invus Public Equities Advisors LLC

2,750,000

2.43%

0.2%

06/30/2018

D. E. Shaw & Co. LP

2,269,100

448,006

0.01%

06/30/2018

Oracle Investment Management, Inc.

1,499,540

1.32%

-47,852

0.73%

06/30/2018

QVT Financial LP

1,469,534

1.3%

-1,526,296

0.83%

06/30/2018

SSgA Funds Management, Inc.

1,416,663

1.25%

-1,760,642

06/30/2018

Northern Trust Investments, Inc.

1,011,384

0.89%

47,185

06/30/2018

Renaissance Technologies LLC

934,315

0.83%

-948,500

06/30/2018

About Agenus

View Profile

Address	3 Forbes Road Lexington Massachusetts 02421 United States
Employees	-
Website	http://www.agenusbio.com
Updated	07/08/2019
Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes AGEN1884, Next-gen CTLA-A, AGEN2034, INCAGN1876, INCAGN1949, Prophage, AutoSynVax, PhosphoSynVax, and AS-21 Stimulon. The company was founded by Garo H.